ALS treatment: biodrug shows “130% increase in survival”
A new acellular biotherapy, unique in the world, is currently being developed to treat people with amyotrophic lateral sclerosis. We ...
Read moreTag: SLA2024
Ice Bucket Challenge: Will you take on the Frozen Challenge to fight Lou Gehrig’s disease?
The ALS Ice Bucket Challenge is celebrating its 10th anniversary! An opportunity to relaunch the challenge to raise funds for ...
Read more
Charcot: “I have the impression that the experimental treatment has slowed the progression of the disease”
At 26, Leah Stavenhagen was diagnosed with amyotrophic lateral sclerosis. While the symptoms quickly set in, a glimmer of hope ...
Read more
ALS: “There are no dietary restrictions to put in place, nor miracle foods!”
On the occasion of our amyotrophic lateral sclerosis awareness week, Pourquoi Docteur interviewed Professor Pierre Jésus, professor of nutrition and ...
Read more
Development of a saliva test for the diagnosis of amyotrophic lateral sclerosis
Yahya El Mir, Founder and President of the biotech ZIWIG, reveals the current developments of a test for the detection ...
Read more
ALS: “My autonomy is stolen from me in every single thing I do”
Having suffered from amyotrophic lateral sclerosis (ALS) for almost two years, Lorène speaks to us clearly about her daily struggle ...
Read more
ALS: Fecal microbiota transplantation improves respiratory failure
Fecal microbiota transplantation improved respiratory failure in two patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ...
Read more
ALS: “Until now, we had a feeling of inevitability, even though there is still hope”
On the occasion of our special week dedicated to amyotrophic lateral sclerosis, Pourquoi docteur takes stock of treatments and research ...
Read more
ALS: the key role of a protein discovered in Charcot’s disease
A team of scientists has discovered that a specific protein could contribute to the development of neurodegenerative pathologies, including Lou ...
Read more
ALS: “Continuing to work allows me to build myself outside of the disease”
Christophe Malsot learned that he had Amyotrophic Lateral Sclerosis (also called Charcot's disease) in 2021. He spoke about his fight ...
Read more
“With the dissolution of the National Assembly, he condemns thousands of sick people to unnecessary agony”
By choosing to dissolve the National Assembly, Emmanuel Macron has reduced to nothing the ongoing discussions concerning the bill on ...
Read more
Charcot’s disease: treatment with AMX0035, between hopes and disillusionment
After generating a great deal of interest, the AMX0035 molecule was ultimately shown to be ineffective in a phase 3 ...
Read more
Saint-Vaast-en-Chaussée: “These people died of ALS over 10 years, so it may be a game of chance”
On the occasion of our special week dedicated to amyotrophic lateral sclerosis, Pourquoi Docteur takes stock of knowledge surrounding this ...
Read more
ALS: discovery of a new way to slow the disease
Researchers have been able to slow the progression of amyotrophic lateral sclerosis by preventing the death of nerve cells in ...
Read more
Charcot’s disease in figures: “it is the least rare rare disease”
Each individual carries a 1 in 300 risk of developing ALS during their lifetime. THE ESSENTIAL Charcot's disease was discovered ...
Read more
Amyotrophic Lateral Sclerosis: “Weight loss is a warning sign”
Luc Dupuis, a research director at Inserm, gives Pourquoi Docteur an update on the non-motor symptoms that can be precursors, ...
Read more
Caregiver’s Place in ALS: ‘I Was My Husband’s Arms and Legs’
Caregivers play a vital role in supporting and caring for the sick person. Hélène Pinel agreed to talk to us ...
Read more